Mobile
browsing
RMB8million
High-end chemical industry
Heze
Joint venture, cooperation and sole proprietorship
Shandong Sirui Biotech has a registered capital of RMB 200 million and mainly engages in the production, R&D and sales of hormone crude drug intermediates.
The hormone crude drug intermediates project with an annual output of 1,000 tons is located in Dingtao District of Heze City. The project covers an area of 200,000 square meters and focuses on building a high-tech park mainly for bio-pharmaceutical products, including 21- hydroxypregnene-1,4,9(11),16- tetraene -3,20- diketone -21- acetate (3-TR), medroxyprogesterone (8-DM) and 4- pregnene -17a,21- diol -3,20- diketone -21- acetate (hydrocortisone intermediates).